Cargando…
Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates
Acute kidney injury (AKI) occurs in ~20% of patients receiving immune checkpoint inhibitor (ICI) therapy; however, only 2–5% will develop ICI-mediated immune nephritis. Conventional tests are nonspecific in diagnosing disease pathology and invasive procedures (i.e. kidney biopsy) may not be feasible...
Autores principales: | Singh, Shailbala, Clemente, Leticia C., Parra, Edwin R., Tchakarov, Amanda, Yang, Chao, Li, Yisheng, Long, James P., Yee, Cassian, Lin, Jamie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519023/ https://www.ncbi.nlm.nih.gov/pubmed/36185804 http://dx.doi.org/10.1080/2162402X.2022.2124678 |
Ejemplares similares
-
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019) -
Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis
por: Lin, Jamie S., et al.
Publicado: (2021) -
Hematologic complications of immune checkpoint inhibitors
por: Kroll, Michael H., et al.
Publicado: (2022) -
Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes
Publicado: (1994) -
T-cell clonotypes in cancer
por: thor Straten, Per, et al.
Publicado: (2004)